These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 17120736
1. P53 regulation of leukemia cells with the blockage of MDM2 by antisense oligonucleotides. Fang M, Ji X, Tang Y, Liu W. J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):414-6. PubMed ID: 17120736 [Abstract] [Full Text] [Related]
2. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Cancer Res; 2000 Oct 15; 60(20):5659-66. PubMed ID: 11059757 [Abstract] [Full Text] [Related]
3. MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. Kondo S, Barnett GH, Hara H, Morimura T, Takeuchi J. Oncogene; 1995 May 18; 10(10):2001-6. PubMed ID: 7761100 [Abstract] [Full Text] [Related]
4. Transfection with mdm2-antisense or wtp53 results in radiosensitization and an increased apoptosis of a soft tissue sarcoma cell line. Grünbaum U, Meye A, Bache M, Bartel F, Würl P, Schmidt H, Dunst J, Taubert H. Anticancer Res; 2001 May 18; 21(3B):2065-71. PubMed ID: 11497299 [Abstract] [Full Text] [Related]
5. Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivation. Mu Z, Hachem P, Agrawal S, Pollack A. Prostate; 2004 Aug 01; 60(3):187-96. PubMed ID: 15176048 [Abstract] [Full Text] [Related]
6. [New insight into the mechanism of p53 inducing leukemia cell apoptosis]. Chen YZ, Wu Y, Liang M, Li NN, Zhang ZX, Lu LH. Zhonghua Xue Ye Xue Za Zhi; 2003 Dec 01; 24(12):640-3. PubMed ID: 14761612 [Abstract] [Full Text] [Related]
7. Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells. Mir R, Tortosa A, Martinez-Soler F, Vidal A, Condom E, Pérez-Perarnau A, Ruiz-Larroya T, Gil J, Giménez-Bonafé P. Int J Cancer; 2013 Apr 01; 132(7):1525-36. PubMed ID: 22961628 [Abstract] [Full Text] [Related]
8. Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme. Prasad G, Wang H, Agrawal S, Zhang R. Anticancer Res; 2002 Apr 01; 22(1A):107-16. PubMed ID: 12017271 [Abstract] [Full Text] [Related]
9. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms. Wang H, Yu D, Agrawal S, Zhang R. Prostate; 2003 Feb 15; 54(3):194-205. PubMed ID: 12518324 [Abstract] [Full Text] [Related]
10. Radiosensitization by antisense anti-MDM2 mixed-backbone oligonucleotide in in vitro and in vivo human cancer models. Zhang Z, Wang H, Prasad G, Li M, Yu D, Bonner JA, Agrawal S, Zhang R. Clin Cancer Res; 2004 Feb 15; 10(4):1263-73. PubMed ID: 14977824 [Abstract] [Full Text] [Related]
11. P53 and Murine Double Mimute 2 (MDM2) Expression Changes and Significance in Different Types of Endometrial Lesions. Jiang Z, Xu W, Dan G, Liu Y, Xiong J. Med Sci Monit; 2016 Dec 07; 22():4786-4793. PubMed ID: 27924072 [Abstract] [Full Text] [Related]
12. Anti-tumor efficacy of a novel antisense anti-MDM2 mixed-backbone oligonucleotide in human colon cancer models: p53-dependent and p53-independent mechanisms. Wang H, Nan L, Yu D, Lindsey JR, Agrawal S, Zhang R. Mol Med; 2002 Apr 07; 8(4):185-99. PubMed ID: 12149568 [Abstract] [Full Text] [Related]
13. The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway. Guo Y, Li Y, Wang FF, Xiang B, Huang XO, Ma HB, Gong YP. Int J Biochem Cell Biol; 2019 Jan 07; 106():8-20. PubMed ID: 30389549 [Abstract] [Full Text] [Related]
14. Growth reduction of a xenotransplanted human soft tissue sarcoma by MDM2 antisense therapy via implanted osmotic minipumps. Würl P, Bartel F, Meye A, Kappler M, Bache M, Schmidt H, Schönfelder M, Taubert H. Int J Oncol; 2002 May 07; 20(5):1087-93. PubMed ID: 11956608 [Abstract] [Full Text] [Related]
15. Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides. Capoulade C, Mir LM, Carlier K, Lécluse Y, Tétaud C, Mishal Z, Wiels J. Blood; 2001 Feb 15; 97(4):1043-9. PubMed ID: 11159535 [Abstract] [Full Text] [Related]
16. Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells. Dong YB, Yang HL, Elliott MJ, McMasters KM. Tumour Biol; 2003 Feb 15; 24(3):130-9. PubMed ID: 14610316 [Abstract] [Full Text] [Related]
17. Rapamycin increases the p53/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells. Kao CL, Hsu HS, Chen HW, Cheng TH. Cancer Lett; 2009 Dec 28; 286(2):250-9. PubMed ID: 19560264 [Abstract] [Full Text] [Related]
18. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts. Fu P, Shen B, Zhao C, Tian G. J Nucl Med; 2010 Nov 28; 51(11):1805-12. PubMed ID: 20956468 [Abstract] [Full Text] [Related]
19. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Chen L, Agrawal S, Zhou W, Zhang R, Chen J. Proc Natl Acad Sci U S A; 1998 Jan 06; 95(1):195-200. PubMed ID: 9419352 [Abstract] [Full Text] [Related]
20. The roles of E6-AP and MDM2 in p53 regulation in human papillomavirus-positive cervical cancer cells. Traidej M, Chen L, Yu D, Agrawal S, Chen J. Antisense Nucleic Acid Drug Dev; 2000 Feb 06; 10(1):17-27. PubMed ID: 10726657 [Abstract] [Full Text] [Related] Page: [Next] [New Search]